$VICR

VINCIARELLI PATRIZIO sold $224K of VICR

VINCIARELLI PATRIZIO (Chairman and CEO) sold 700 shares of VICOR CORP (VICR) at $319.50 ($0.22M total) on 2026-06-01 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 2, 2026, 7:14 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 2, 2026, 7:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The disclosure updates the insider trading record but does not introduce new guidance, contracts, litigation, or operational results.

02

Market read

Traders may briefly reassess sentiment/positioning around VICR, but the 10b5-1 framing makes it unlikely to drive a fundamental repricing.

03

What to watch

The sale is small relative to post-transaction holdings and explicitly tied to a pre-arranged plan, which reduces interpretability as a discretionary bearish signal.

Relevance 6/10Novelty 3/10Timing: SEC Form 4 filed June 2 for a June 1 insider sale

Background

The article is an SEC Form 4 insider transaction disclosure for Vicor Corp, reporting an open-market sale by the CEO/Chairman under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold 700 shares in an open-market transaction disclosed via SEC Form 4 on June 1 under a 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any effect is more sentiment/positioning than new fundamental information.

Evidence & confidence

The filing is an ownership-change disclosure with a stated pre-arranged 10b5-1 plan; it provides a datapoint (sale size/price) but no new company-specific operating or financial catalyst.

Market effects

Minimal; this is company-specific insider activity with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated or larger-than-usual insider sales can be interpreted by some traders as confidence erosion, especially if coinciding with other negative signals.

Key entities

  • VICOR CORP

    Subject of the SEC Form 4 insider transaction disclosure.

  • VINCIARELLI PATRIZIO

    Chairman and CEO who sold 700 shares under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: